Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway
暂无分享,去创建一个
Xuequn Shang | Wenbin Liu | Xuequn Shang | L. Shen | Wenbin Liu | Xianbin Li | Xianbin Li | Liangzhong Shen | Liangzhong Shen
[1] W. Qu,et al. Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells. , 2014, International journal of clinical and experimental pathology.
[2] K. Ho,et al. A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.
[3] Gabriele Sales,et al. graphite - a Bioconductor package to convert pathway topology to gene network , 2012, BMC Bioinformatics.
[4] Chunquan Li,et al. A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways , 2015, Journal of The Royal Society Interface.
[5] C. Ahn,et al. A Splicing Variant of NME1 Negatively Regulates NF-κB Signaling and Inhibits Cancer Metastasis by Interacting with IKKβ* , 2014, The Journal of Biological Chemistry.
[6] M. Spitz,et al. Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer , 2007, Clinical Cancer Research.
[7] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[8] Li‐jun Wu,et al. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. , 2011, International journal of molecular medicine.
[9] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[10] K. Nan,et al. SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. , 2014, Cancer letters.
[11] P. Khatri,et al. Global functional profiling of gene expression ? ? This work was funded in part by a Sun Microsystem , 2003 .
[12] M. Ptito,et al. Concerted Action of CB1 Cannabinoid Receptor and Deleted in Colorectal Cancer in Axon Guidance , 2011, The Journal of Neuroscience.
[13] B. Vincenzi,et al. Cell cycle alterations and lung cancer. , 2006, Histology and histopathology.
[14] M. Qadan,et al. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer. , 2010, Genetic testing and molecular biomarkers.
[15] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[16] K. Straif,et al. A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.
[17] Nathalia Amado,et al. Flavonoids and Wnt/β-Catenin Signaling: Potential Role in Colorectal Cancer Therapies , 2014, International journal of molecular sciences.
[18] T. Hoey,et al. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells. , 2014, Cancer research.
[19] Qi Zheng,et al. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis , 2008, Nucleic Acids Res..
[20] V. Golubovskaya,et al. Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy , 2013, Cancer biology & therapy.
[21] Christian Baumgartner,et al. Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer. , 2013, Cancer treatment reviews.
[22] Y. Dobashi. Cell cycle regulation and its aberrations in human lung carcinoma , 2005, Pathology international.
[23] R. Roskoski. The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.
[24] S. So,et al. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. , 2009, Gastroenterology.
[25] Chunquan Li,et al. The Implications of Relationships between Human Diseases and Metabolic Subpathways , 2011, PloS one.
[26] A Coldman,et al. Evaluation of immunohistochemical markers in non‐small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers , 2004, The Journal of pathology.
[27] Yong Lin,et al. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. , 2011, Frontiers in bioscience.
[28] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[29] B. Simon,et al. A Gene Expression and Pre-mRNA Splicing Signature That Marks the Adenoma-Adenocarcinoma Progression in Colorectal Cancer , 2014, PloS one.
[30] T. Miyazaki,et al. Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: Results of a prospective randomized trial , 2009, Surgery Today.
[31] M. V. Van Dyke,et al. Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines. , 2007, Cancer letters.
[32] Chun Xing Li,et al. Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction , 2014, Oncology letters.
[33] M. Cooke,et al. Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate , 2010, Nature Reviews Immunology.
[34] M. Ilyas,et al. Nuclear expression of phosphorylated focal adhesion kinase is associated with poor prognosis in human colorectal cancer. , 2014, Anticancer research.
[35] A. Sadikot,et al. Critical Roles for the Netrin Receptor Deleted in Colorectal Cancer in Dopaminergic Neuronal Precursor Migration, Axon Guidance, and Axon Arborization , 2010, Neuroscience.
[36] L. Ylagan,et al. The Prognostic Significance of Focal Adhesion Kinase Expression in Stage I Non–Small-Cell Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[37] Jingyu Yang,et al. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling , 2013, British Journal of Cancer.
[38] Sandrine Dudoit,et al. More power via graph-structured tests for differential expression of gene networks , 2012, 1206.6980.
[39] I. Kawase,et al. Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study , 2014, BMC Cancer.
[40] Monica Chiogna,et al. Along signal paths: an empirical gene set approach exploiting pathway topology , 2012, Nucleic acids research.
[41] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[42] S. Sang,et al. Induction of Lung Cancer Cell Apoptosis through a p53 Pathway by [6]-Shogaol and Its Cysteine-Conjugated Metabolite M2 , 2014, Journal of agricultural and food chemistry.
[43] Atul J. Butte,et al. Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..
[44] N. Yoo,et al. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability , 2013, Pathology.
[45] F. Zheng,et al. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine , 2014, Journal of experimental & clinical cancer research : CR.
[46] F. Marincola,et al. Epstein–Barr virus microRNAs and lung cancer , 2011, British Journal of Cancer.
[47] A. Harris,et al. Notch3 signalling promotes tumour growth in colorectal cancer , 2011, The Journal of pathology.
[48] Jun Zhou,et al. Function and mode of action of cytohesins in the epidermal growth factor pathway in colorectal cancer cells , 2012, Oncology letters.
[49] Raphael Kopan,et al. The Notch pathway: democracy and aristocracy in the selection of cell fate , 1996, Current Opinion in Neurobiology.
[50] Thomas Lengauer,et al. Statistical Applications in Genetics and Molecular Biology Calculating the Statistical Significance of Changes in Pathway Activity From Gene Expression Data , 2011 .
[51] Mei Liu,et al. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival , 2004, Oncogene.
[52] Tom D. Bunney,et al. Phosphoinositide signalling in cancer: beyond PI3K and PTEN , 2010, Nature Reviews Cancer.
[53] B. Osborne,et al. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents , 2003, Oncogene.
[54] Jian-Hong Wu,et al. Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK , 2013, PloS one.
[55] Joaquín Dopazo,et al. Understanding disease mechanisms with models of signaling pathway activities , 2014, BMC Systems Biology.
[56] Colin N. Dewey,et al. Initial sequencing and comparative analysis of the mouse genome. , 2002 .
[57] A. Sweet-Cordero,et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon , 2008, Nature Genetics.
[58] O. Tawfik,et al. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. , 2014, Carcinogenesis.
[59] K. Kono,et al. Expression of signal transducing T‐cell receptor ζ molecules after adoptive immunotherapy in patients with gastric and colon cancer , 1998, International journal of cancer.
[60] Wafik S El-Deiry,et al. TRAIL and apoptosis induction by TNF-family death receptors , 2003, Oncogene.
[61] E. Małusecka,et al. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study. , 1999, Folia histochemica et cytobiologica.
[62] Lin Zhu,et al. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues. , 2013, International journal of oncology.
[63] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] P. Khatri,et al. Global functional profiling of gene expression. , 2003, Genomics.
[65] Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome , 2002, Nature.
[66] Yuan Wang,et al. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[67] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[68] Helen X. Chen,et al. Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients , 2014, Investigational New Drugs.
[69] I. Abdulkader,et al. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study. , 2005, Oncology Report.
[70] S. Morini,et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies , 2011, Journal of carcinogenesis.
[71] Yan Wang,et al. Characterizing the Network of Drugs and Their Affected Metabolic Subpathways , 2012, PloS one.
[72] D. Karunagaran,et al. Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620. , 2014, European Journal of Pharmacology.
[73] Ming-wu Chen,et al. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data , 2014, Tumor Biology.
[74] Julia B. Cordero,et al. Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation , 2013, Gut.
[75] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[76] J. Bartlett,et al. Extra‐Intestinal Manifestations of Salmonella Infections , 1987, Medicine.
[77] C. Simone,et al. p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. , 2014, World journal of gastroenterology.
[78] Vassilis G Gorgoulis,et al. Dual function of p38α MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. , 2014, Cancer cell.
[79] P. Khatri,et al. Profiling gene expression using onto-express. , 2002, Genomics.
[80] Yong Cai,et al. Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma. , 2014, International journal of oncology.
[81] G. Samonis,et al. Salmonella enterica Pneumonia in a Patient with Lung Cancer , 2003, Journal of Clinical Microbiology.
[82] M. Unlu,et al. Primary lung cancer coexisting with active pulmonary tuberculosis. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[83] Richard D Neal,et al. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.
[84] L. Havel,et al. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity , 2014, Oncogene.
[85] S. Wacholder,et al. Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.
[86] Hui-Jen Chang,et al. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer. , 2011, Oncology reports.
[87] H. Modjtahedi,et al. Prognostic significance and targeting of HER family in colorectal cancer. , 2013, Frontiers in bioscience.
[88] Chunquan Li,et al. SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.